SLC9A1 and colorectal carcinoma: Co-administration of DMH and non-steroidal anti-inflammatory drugs (NSAIDs) such as the CRC-preventing sulindac and celecoxib leads to significant decreases in NHE1 expression implying that NHE1 contributes to colonic tumor progression (Vaish and Sanyal, 2012).